References:

The Cannon^® II Plus is indicated for use in attaining long-term vascular access for hemodialysis and apheresis. The Cannon^® II Plus is inserted percutaneously and is preferentially placed into the internal jugular (IJ) vein. Alternately, this catheter may be inserted into the subclavian vein although the jugular vein is the preferred site. Catheters greater than 40 cm are intended for femoral vein insertion. The Cannon^® II Plus is intended for use in adult patients. Refer to the Instructions for Use for a complete listing of the indications, contraindications, warnings and precautions. Information in this material is not a substitute for the product Instructions for Use. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. Not all products are available in all regions. Please contact customer service to confirm availability in your region. Hibiclens is a registered trademark of Regent Medical Limited. ChloraPrep is a registered trademark of Carefusion 2200, Inc. Bactroban is a registered trademark of GlaxoSmithKline, LLC. ExSept Plus is a registered trademark of Angelini Pharma, Inc. Teleflex, the Teleflex logo, Arrow, Cannon and SmartSeal are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. MC-004286 Rev 0 Revised: 07/2018.